Showing results (1791-1800 of 1,979) with videos related to
Sort By:
Pageof 198
Cancer|October 9, 2019
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancerDan Fan, Jennifer Ma, Andrew C Bell, et al.Cancer Research|October 24, 2012
Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cellsLee-Hwa Tai, Christiano Tanese de Souza, Simon Bélanger, et al.Hepatology (Baltimore, Md.)|August 18, 2016
Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiationVolker M Lauschke, Sabine U Vorrink, Sabrina M L Moro, et al.Nature Microbiology|September 25, 2019
A genomic view of the reef-building coral Porites lutea and its microbial symbiontsSteven J Robbins, Caitlin M Singleton, Cheong Xin Chan, et al.Frontiers in Immunology|January 7, 2025
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.Journal of Magnetic Resonance Imaging : JMRI|February 27, 2025
A Systematic Review of the Variability of Ventilation Defect Percent Generated From Hyperpolarized Noble Gas Pulmonary Magnetic Resonance ImagingVanessa M Diamond, Laura C Bell, Jeffrey N Bone, et al.Clinical Trials (London, England)|November 6, 2009
Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trialMargaret C Bell, Patricia R Robuck, Elizabeth C Wright, et al.Frontiers in Immunology|May 7, 2025
Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.Angewandte Chemie (International Ed. in English)|May 28, 2019
Low-Temperature Growth of Carbon Nanotubes Catalyzed by Sodium-Based IngredientsRichard Li, Erica F Antunes, Estelle Kalfon-Cohen, et al.Oncoimmunology|February 6, 2018
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cellsTiphaine Delaunay, Mathilde Violland, Nicolas Boisgerault, et al.Pageof 198